Myriad Genetics
MYGN
MYGN
186 hedge funds and large institutions have $2B invested in Myriad Genetics in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 194 → 186 (-8)
5.97% less ownership
Funds ownership: 110.38% → 104.41% (-6%)
28% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 29
Holders
186
Holding in Top 10
1
Calls
$6.32M
Puts
$324K
Top Buyers
| 1 | +$17.9M | |
| 2 | +$16.6M | |
| 3 | +$15M | |
| 4 |
Millennium Management
New York
|
+$13.1M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$8.13M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$7.27M | |
| 3 | -$7.26M | |
| 4 |
Goldman Sachs
New York
|
-$3.84M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$3.22M |